Capecitabine/Oxaliplatin, a Safe and Active First-Line Regimen for Older Patients Metastatic Colorectal Cancer: Post Hoc Analysis of a Large Phase II Study

In the context of an aging population, XelOx provides a highly effective and tolerable first-line treatment for patients with metastatic CRC.